Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD

Prevalence of Prescribed Attention-Deficit Hyperactivity Disorder Medications and Diagnosis among Canadian Preschoolers and School-Age Children: 1994–2007

(2017) Marie-Christine Brault et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Long-term effects of stimulants on neurocognitive performance of Taiwanese children with attention-deficit/hyperactivity disorder

(2013) Ching-Shu Tsai et al.   BMC Psychiatry

Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case

(2013) Hoa H. Le et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Practitioner Review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

(2013) Samuele Cortese et al.   JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY

The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews

(2013) Rebecca M. Turner et al.   PLoS One

The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective

(2012) Anton Pottegård et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

No Beneficial Effects of Adding Parent Training to Methylphenidate Treatment for ADHD + ODD/CD Children

(2012) Eyup Sabri Ercan et al.   Journal of Attention Disorders

Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States

(2012) Jalpa A. Doshi et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

(2011) Raveen Hanwella et al.   BMC Psychiatry

Pharmacologic Treatment of Attention-Deficit/Hyperactivity Disorder in Children: Incidence, Prevalence, and Treatment Patterns in The Netherlands

(2011) Paul Hodgkins et al.   CLINICAL THERAPEUTICS

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

(2011) Yu-Shu Huang et al.   CNS DRUGS

To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

(2011) Gigi H.H. van de Loo-Neus et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Do Phenotypic Characteristics, Parental Psychopathology, Family Functioning, and Environmental Stressors Have a Role in the Response to Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder?

(2011) Rodrigo Chazan et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

(2011)   PEDIATRICS

Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate

(2011) Liang-Jen Wang et al.   PSYCHONEUROENDOCRINOLOGY

Use of ADHD drugs in the Nordic countries: a population-based comparison study

(2010) H. Zoëga et al.   ACTA PSYCHIATRICA SCANDINAVICA

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

(2010) Sandra JJ Kooij et al.   BMC Psychiatry

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

(2010) David Fraguas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes

(2010) Stephen V. Faraone et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

(2009) Stephen V. Faraone et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY